Roche Holdings AG's RHHBY market capitalization grew by 13.8%, spurred by the FDA’s approval of two key products, Ocrevus Zunovo for multiple sclerosis and Tecentriq Hybreza for oncology indications, ...

TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...

Roche’s market capitalisation growth of 13.8% was driven by FDA approvals for two key products in September 2024: Ocrevus ...

Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...

Another Trump term could spur Europe’s efforts to stand on its own, but it is far from clear its leaders will seize the moment this time. By Steven Erlanger Beijing is expecting more ...

Russians close to the Kremlin voiced optimism that Donald J. Trump could help end the war in Ukraine on Russia’s terms. Vladimir V. Putin said Mr. Trump’s remarks on ending the war “deserve ...

Federal officials are investigating a new outbreak of E. coli O121:H19. A source of the pathogen has not yet been identified. The investigation is in its early stages, and 33 patients have been ...

Nov. 1, 2024 — Microplastics have been steadily increasing in freshwater environments for decades and are directly tied to rising global plastic production since the 1950s, according to a new ...

Roche has said it will continue with talks with UK health officials to bring its multiple sclerosis drug Ocrevus to NHS patients with primary progressive disease, after NICE said it was not cost ...

Nov. 6, 2024 — New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment ...

‘Strikes at heart of Putin’s war machine’ also target people involved in Ukraine war and Salisbury nerve agent attack. Russia will gain from Trump’s pressure on Ukraine to negotiate a ...